Evidence map›Paper›PMID 34759745›Full record

ArticleSaudi journal of biological sciences2021

CircRNA PLOD2 enhances ovarian cancer propagation by controlling miR-378.

Xiaoqiang Wei, Hongmei Lv, Shaowen Yang, Xiufeng Yang

Abstract read
In one paragraph

Article in Saudi journal of biological sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Research progress of the netrins and their receptors in cancer.Journal of cellular and molecular medicine · 2024
    Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. An interactive analysis of the mouse oviductal miRNA profiles.Frontiers in cell and developmental biology · 2022
    Article
  10. Depicting the Implication of miR-378a in Cancers.Technology in cancer research & treatment
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xiaoqiang WeiGynecological Department, Qingdao Women and Children 's Hospital, Qingdao University Affiliated Qingdao Women and Children 's Hospital, 266011 Qingdao, P. R. China.
Hongmei LvGynecological Department,Qingdao Central Hospital, The Second Clinical Hospital of Qingdao University, 266042 Qingdao, P. R. China.
Shaowen YangGynecological Department,Qingdao Central Hospital, The Second Clinical Hospital of Qingdao University, 266042 Qingdao, P. R. China.
Xiufeng YangGynecological Department,Qingdao Central Hospital, The Second Clinical Hospital of Qingdao University, 266042 Qingdao, P. R. China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It has been confirmed that circular RNA participates in tumorgenesis through a variety of ways, so it may be used as a molecular marker for tumor diagnosis and treatment. In this study, the expression of circ-LOPD2 in ovarian cancer tissues and cell lines was detected by qRT-PCR and Western blot. The dual luciferase report was used to verify the target of circ-LOPD2, and the silencing and overexpression of circ-CSPP1 in cell lines was used to explore its relationship with miRNA-378. The cell proliferation was detected by CCK8 method, and the expression level of miRNA-378 was detected by qRT-PCR. The results showed that circ-LOPD2 was highly expressed in ovarian cancer (OC) tissues, circ-LOPD2 expression levels were higher in OVCAR3 and A2780, and circ-LOPD2 expression levels in CAOV3 were lower. After silencing circ-LOPD2, the growth ability of OVCAR3 and A2780 cells decreased, while overexpression of circ-LOPD2 led to the opposite result. We also found that miR-378 is a target of circ-LOPD2. Silencing circ-LOPD2 will increase the expression of miR-378, and overexpression of circ-LOPD2 will decrease the expression of miR-378. In summary, our results show that circ-LOPD2 as a miR-378 sponge promotes the proliferation of ovarian cancer cells, which may in turn promote the development of OC.

Indexed as

DiagnosisGene expressionOvarian cancerPrognosisSilencing

Identifiers

PMID34759745
PMCPMC8568717

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.